<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
DRUGABUSE SCIENCES, INC.
-------------------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
California 94-3222724
------------------------------------ ----------------------------
(STATE OF INCORPORATION OR ORGANIZATION) (I.R.S. Employer
Identification Number)
1430 O'Brien Drive
Menlo Park, California 94025
------------------------------------ ----------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
If this Form relates to the registration of a
class of debt securities and is effective upon
filing pursuant to General Instruction A(c)(1)
please check the following box.
If this Form relates to the registration of a
class of debt securities and is to become
effective simultaneously with the effectiveness
of a concurrent registration statement under
the Securities Act of 1933 pursuant to General
Instruction A(c)(2) please check the following
box.
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
TITLE OF EACH CLASS NAME OF EACH EXCHANGE ON WHICH
TO BE SO REGISTERED EACH CLASS IS TO BE REGISTERED
Not Applicable Not Applicable
- -------------------------------- -------------------------------------
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
COMMON STOCK, $0.001 PAR VALUE
- ------------------------------------------------------------------------------
(TITLE OF CLASS)
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
--------------------------------------------------------
Incorporated herein by reference to the Description of Capital
Stock section of the Company's Registration Statement on Form S-1 (File No.
333-96049).
ITEM 2. EXHIBITS.
---------
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
------- -----------
<S> <C>
3.1 Amended and Restated Articles of Incorporation of Registrant, as
amended to date - incorporated herein by reference to Exhibit 3.1
to the Company's Registration Statement on Form S-1 (File No.
333-96049).
3.2 Form of Amended and Restated Articles of Incorporation of
Registrant to be filed upon the closing of the Registrant's
initial public offering - incorporated herein by reference to
Exhibit 3.2 to the Company's Registration Statement on Form S-1
(File No. 333-96049).
3.3 Bylaws of Registrant - incorporated herein by reference to
Exhibit 3.3 to the Company's Registration Statement on Form S-1
(File No. 333-96049).
3.4 Form of Amended and Restated Bylaws of Registrant to be
effective upon the closing of the Registrant's initial public
offering - incorporated herein by reference to Exhibit 3.4 to the
Company's Registration Statement on Form S-1 (File No. 333-96049).
</TABLE>
2
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the registrant has duly caused this registration
statement to be signed on its behalf by the undersigned, thereto duly
authorized.
DRUGABUSE SCIENCES, INC.
Date: March 28, 2000 By: /s/ Elizabeth M. Greetham
-----------------------------------
Elizabeth M. Greetham
Senior Vice President, Business
Development, Director and
Chief Financial Officer
<PAGE>
EXHIBITS
--------
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
------- -----------
<S> <C>
3.1 Amended and Restated Articles of Incorporation of Registrant, as
amended to date - incorporated herein by reference to Exhibit 3.1
to the Company's Registration Statement on Form S-1 (File No.
333-96049).
3.2 Form of Amended and Restated Articles of Incorporation of
Registrant to be filed upon the closing of the Registrant's
initial public offering - incorporated herein by reference to
Exhibit 3.2 to the Company's Registration Statement on Form S-1
(File No. 333-96049).
3.3 Bylaws of Registrant - incorporated herein by reference to
Exhibit 3.3 to the Company's Registration Statement on Form S-1
(File No. 333-96049).
3.4 Form of Amended and Restated Bylaws of Registrant to be effective
upon the closing of the Registrant's initial public offering -
incorporated herein by reference to Exhibit 3.4 to the Company's
Registration Statement on Form S-1 (File No. 333-96049).
</TABLE>
